2019-003351-11: Study to the effects of using "triple therapy" on the health status of COPD patients with characteristics of asthma Een onderzoek naar het effect van het gebruik van “triple therapie” op de gezondheids-status van COPD-patiënten met kenmerken van asthma |
|
|
| Not yet recruiting | 4 | 316 | Europe | Trimbow, Pressurised inhalation, Inhalation powder, Trimbow, Anoro or Duaklir Genuair Inhalationpowder or Ultibro Breezhaler or Spiolto Respimat | GPRI, General Practitioners Research Institute (GPRI) | Chronic Obstructive Pulmonary Disease (COPD) patients COPD patiënten, COPD COPD, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
| Active, not recruiting | 4 | 320 | Europe | Administration via pressurized metered dose inhaler (pMDI) | Chiesi Farmaceutici S.p.A. | Asthma | 04/24 | 04/24 | | |
